NovAccess Global Inc. (OTCMKTS:XSNX) Short Interest Up 408.8% in October

NovAccess Global Inc. (OTCMKTS:XSNX) was the target of a large increase in short interest in the month of October. As of October 15th, there was short interest totalling 17,300 shares, an increase of 408.8% from the September 30th total of 3,400 shares. Based on an average daily trading volume, of 87,100 shares, the days-to-cover ratio is currently 0.2 days.

NovAccess Global Stock Performance

OTCMKTS XSNX opened at $0.00 on Friday. The company’s fifty day simple moving average is $0.01 and its 200-day simple moving average is $0.01. The stock has a market cap of $178,412.00, a P/E ratio of -0.03 and a beta of 1.82. NovAccess Global has a 52 week low of $0.00 and a 52 week high of $0.06.

NovAccess Global Company Profile

NovAccess Global Inc, a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. It specializes in cutting-edge research related to utilizing a patient’s immune system to attack the cancer. The company was incorporated in 1997 and is headquartered in Chagrin Falls, Ohio.